You brought it up at your last appointment. Maybe you'd done the research, checked your BMI, read the studies. Your doctor listened, nodded, and then said some version of "I don't think that's right for you" or "let's try lifestyle changes first" or just changed the subject. You left without a prescription.
You're not alone, and you're probably not out of options either.
Why Primary Care Doctors Say No
There are real reasons this happens. Some are legitimate medical considerations. Others are system problems that have nothing to do with your actual health.
Your BMI doesn't hit the cutoff
The FDA approved Wegovy for adults with a BMI of 30 or higher, or 27 and above if you have at least one weight-related health condition like high blood pressure, sleep apnea, or type 2 diabetes. Zepbound has the same criteria. If your BMI is 26 or 27 with no diagnosed conditions, most doctors won't prescribe, and technically they'd be going off-label if they did. Some people are right on the edge of the criteria and still get turned down because their doctor isn't sure the paperwork will hold up with insurance.
Use our BMI calculator to confirm where you actually stand. The cutoffs are stricter than a lot of people realize.
Insurance constraints shape the conversation
Primary care doctors know that a Wegovy prescription without insurance coverage means you'll be staring at a $1,100 to $1,300 monthly bill at the pharmacy. Some doctors will preemptively avoid prescribing because they don't want to set you up for sticker shock, or because they've seen patients start the medication and then stop when coverage gets denied. The result is a doctor who technically could prescribe but chooses not to because the access path looks too hard.
This is frustrating, and it's also solvable. Dedicated GLP-1 insurance coverage navigation is something a lot of weight loss clinics do every day. They know the prior authorization process, they know which plans approve and which ones fight it, and they write those appeals for a living. Your PCP probably doesn't.
Unfamiliarity with the medications
GLP-1 medications have moved fast. Ozempic was approved for type 2 diabetes in 2017. Wegovy, the weight loss version of the same drug (semaglutide), got approved in 2021. Mounjaro came in 2022, and Zepbound in late 2023. Tirzepatide, the active ingredient in both Mounjaro and Zepbound, targets two hunger-regulating hormones instead of one, which is part of why trials showed 20 to 22% average weight loss in SURMOUNT-1 at the highest dose.
A primary care doctor managing hundreds of patients across dozens of conditions may not have kept up with the nuances of GLP-1 prescribing. They may not know the difference between Ozempic and Wegovy from a regulatory standpoint (they're the same drug at different doses, approved for different things). They may not know how to handle a prior authorization for Zepbound. The gap between knowing a drug exists and knowing how to prescribe it effectively is wider than it looks.
Liability worries and "wait and see"
Some doctors are cautious about new-ish medications, especially with patients who have other conditions that complicate the picture. There's also a real pattern where doctors recommend "diet and exercise first" not because it's likely to work on its own, but because it gives them cover. It's the path of least resistance in a 15-minute appointment. This doesn't make it right, but it explains the dynamic.
What Most People Do Next
The short answer: they find a provider who specializes in this. Here's what that usually looks like.
Weight loss clinics and obesity medicine specialists
Clinics that specialize in medical weight loss do this all day. They know the eligibility criteria, they handle insurance, they manage side effects, they adjust doses. A good one is genuinely better than a generalist PCP for this specific issue, not because PCPs are bad doctors, but because this is niche enough that specialization matters.
You can search our directory of GLP-1 clinics near you. Most offer free initial consultations. Some work entirely through telehealth, which makes the first appointment a lot easier.
Telehealth weight loss providers
Telehealth has genuinely changed access to GLP-1 medications. Platforms like Ro Body, Hims/Hers, and LifeMD, along with hundreds of independent telehealth weight loss clinics, can prescribe Wegovy, Ozempic, Mounjaro, and Zepbound via video visit. You do a live consultation, the provider reviews your history, and if you qualify, the prescription goes to a pharmacy or ships directly to you.
The quality varies. Some telehealth providers are careful and thorough. Others are closer to a prescription vending machine with a video call in the middle. Read reviews, check what the follow-up looks like, and make sure you're getting actual monitoring, not just a recurring prescription. Our telehealth vs. in-person guide goes deeper on what to look for. You can also browse telehealth GLP-1 providers in our directory.
Asking your doctor to reconsider
This is underused. If your doctor's concern was insurance or paperwork, coming back with a clear understanding of the prior authorization process, your specific insurance plan's requirements, and a request to submit for approval can change the outcome. Print your BMI calculation. Bring documentation of any weight-related conditions. Make the medical necessity case yourself, clearly.
If the concern was genuine medical caution, ask for specifics. "What would need to be true for you to feel comfortable prescribing this?" Sometimes there's a real answer. Sometimes the answer reveals that the hesitation isn't clinical at all.
How to Improve Your Chances
Whether you go back to your PCP or find a new provider, a few things make a real difference.
Know your eligibility before the appointment. Confirm your BMI meets the criteria (30+, or 27+ with a qualifying condition). Have your list of relevant health conditions written down: high blood pressure, prediabetes, sleep apnea, high cholesterol, and joint problems all count. Providers are looking for medical necessity, so come prepared to make that case.
Know which drug you're asking about. Ozempic is FDA-approved for type 2 diabetes. Wegovy is approved for weight management. They're both semaglutide, but insurers and regulators treat them differently. If you don't have diabetes, you're asking for Wegovy or Zepbound, not Ozempic. Getting this wrong signals that you haven't done the homework and can make the provider more cautious, not less.
Ask about insurance coverage upfront. Contact your insurer before the appointment and ask directly: does my plan cover Wegovy or Zepbound for weight management? What are the prior authorization requirements? What BMI documentation do you need? Bring that information to the appointment. Providers are much more willing to engage when you've already done the coverage legwork. Our GLP-1 insurance coverage guide breaks down what to ask.
Be specific about what you've already tried. Prior authorization requests almost always ask about previous weight loss attempts. Diet programs, calorie counting, exercise programs, other medications: document what you've done and what happened. This isn't just for the paperwork. It also helps the provider understand your situation and take the conversation more seriously.
Consider a specialist over a generalist. If your PCP has said no twice and you clearly qualify on paper, it's not disloyal to seek a second opinion from someone who specializes in obesity medicine. You wouldn't stay with a cardiologist who didn't know current treatment guidelines. The same logic applies here.
A Note on Ozempic Specifically
A lot of people search for "how to get Ozempic" when what they actually want is a GLP-1 medication for weight loss. Ozempic is semaglutide, but it's approved for type 2 diabetes. Prescribing it for weight loss without a diabetes diagnosis is off-label, which is legal but harder to get covered and means your doctor is stepping outside the standard guidance. Some do it. Many don't.
If weight loss is your goal and you don't have type 2 diabetes, the right ask is Wegovy (also semaglutide, different approval) or Zepbound (tirzepatide). Same class of medication, same basic mechanism, prescribed for the right indication. Getting the drug name right matters more than most people realize when you're navigating this process.
The Bottom Line
A doctor saying no is not the end of this. The real question is why they said no. BMI criteria, insurance complexity, and unfamiliarity with GLP-1 prescribing are all solvable problems. Finding a weight loss clinic or telehealth provider who does this full-time is usually the fastest path forward.
Talk to your doctor about your specific situation before starting any new medication. And if they say no, come back with better information or find someone who specializes in this.
Find a GLP-1 clinic near you in our directory, or browse all clinics by state to find a specialist who can actually help.